Gilles Philippus Van Wezel

This inventor holds 7 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Leiden University, Academisch Ziekenhuis Leiden (h.o.d.n. Lumc), Friedrich-Alexander-Universitat Erlangen-Nürnberg. Active years: 2006-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gilles Philippus Van Wezel. Retrieved from https://idiyas.com/inventor/gilles-philippus-van-wezel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 3)

% Patents Active = 85.7

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 11(Granted Patents)

Location History:

Oegstgeest, NL (2012 - 2017)
Leiden, NL (2006 - 2020)
Heemstede, NL (2023 - 2024)

Company Filing History:

Academisch Ziekenhuis Leiden (h.o.d.n. Lumc)

patents

1 out of 116

Friedrich-Alexander-Universitat Erlangen-Nürnberg

patents

4. 1 out of 14

Rijksuniversiteit Te Leiden

where one patent can have more than one assignee

Years Active: 2006-2024

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12037372 - Bioactive peptides derived from snakes (2024-07-16),

2. 11680088 - Bioactive peptides derived from snakes (2023-06-20),

3. 10696685 - Polyketides, methods of use and preparation (2020-06-30),

4. 9834773 - Methods and means for metabolic engineering and improved product formation by micro-organisms (2017-12-05),

5. 9617592 - Screening method for micro-organisms and methods for the production of a product (2017-04-11),

6. 8313929 - Growth characteristics of filamentous microorganisms (2012-11-20),

7. 7022526 - Reducing branching and enhancing fragmentation in culturing filamentous microorganisms (2006-04-04),

Title: Innovations of Gilles Philippus Van Wezel

Introduction

Gilles Philippus Van Wezel is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of bioactive peptides, particularly those derived from snakes. With a total of seven patents to his name, Van Wezel's work focuses on the application of these peptides in combating various infections and inflammatory conditions.

Latest Patents

One of his latest patents involves bioactive peptides derived from snakes. This patent discloses the potential of snake-derived peptides to inhibit bacterial, fungal, viral, and parasitic infections. Additionally, these peptides are also useful in the treatment of inflammatory conditions and cancers. The innovative nature of this research highlights the importance of exploring natural sources for medical advancements.

Career Highlights

Throughout his career, Van Wezel has been associated with esteemed institutions such as Universiteit Leiden and Academisch Ziekenhuis Leiden, known as LUMC. His work in these organizations has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Some of his notable coworkers include Harald Martijn Ijsbrand Kerkkamp and Michael Keith Richardson. Their collaboration has likely enriched the research environment and fostered innovative ideas in the field of bioactive peptides.

Conclusion

Gilles Philippus Van Wezel's contributions to the field of bioactive peptides demonstrate his commitment to innovation and research. His patents reflect a promising avenue for medical applications, particularly in treating infections and inflammatory diseases.

Profile summary based on public USPTO records.